S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)

Supernus Pharmaceuticals (SUPN) Insider Trading & Ownership

$30.38
-1.62 (-5.06%)
(As of 02:22 PM ET)

Supernus Pharmaceuticals (NASDAQ:SUPN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.76%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.16 M
Get SUPN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Supernus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SUPN Insider Buying and Selling by Quarter

Supernus Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/21/2024Padmanabh P BhattVPSell14,491$35.31$511,677.21  
3/19/2024Padmanabh P BhattVPSell12,364$35.31$436,572.84  
3/12/2024Padmanabh P BhattVPSell3,884$32.99$128,133.16  
2/26/2024Padmanabh P BhattVPSell5,000$30.21$151,050.00  
1/10/2024Tami Tillotson MartinVPSell8,000$27.91$223,280.00  
11/15/2023Frederick M HudsonDirectorSell9,093$28.50$259,150.50  
11/14/2023Frank MottolaSVPSell1,110$28.13$31,224.30  
8/30/2023Tami Tillotson MartinVPSell8,100$32.00$259,200.00  
8/25/2023Tami Tillotson MartinVPSell5,135$31.59$162,214.65  
(Data available from 1/1/2013 forward)

SUPN Insider Trading Activity - Frequently Asked Questions

Who is on Supernus Pharmaceuticals's Insider Roster?

The list of insiders at Supernus Pharmaceuticals includes Frank Mottola, Frederick M Hudson, Jack A Khattar, Padmanabh P Bhatt, and Tami Tillotson Martin. Learn more on insiders at SUPN.

What percentage of Supernus Pharmaceuticals stock is owned by insiders?

8.76% of Supernus Pharmaceuticals stock is owned by insiders. Learn more on SUPN's insider holdings.

Which Supernus Pharmaceuticals insiders have been selling company stock?

The following insiders have sold SUPN shares in the last 24 months: Frank Mottola ($203,256.50), Frederick M Hudson ($259,150.50), Jack A Khattar ($4,407,252.57), Padmanabh P Bhatt ($1,876,568.73), and Tami Tillotson Martin ($989,494.65).

How much insider selling is happening at Supernus Pharmaceuticals?

Insiders have sold a total of 222,538 Supernus Pharmaceuticals shares in the last 24 months for a total of $7,735,722.95 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:SUPN) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners